Frequency of Provider Contact After FDA Advisory on Risk of Pediatric Suicidality With SSRIs
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The Food and Drug Administration (FDA) issued a public health advisory in October 2003 on the risk of suicide in pediatric patients taking antidepressants and advised maintaining "close supervision" of such patients. In this study, the authors compared trends in the frequency of provider contacts for patients with depression before and after the advisory was issued. METHOD: Retrospective cohorts of children (N=27,370) and adults (N=193,151) with new episodes of depression treated with antidepressants were created from a national claims database of managed care plans (1998-2005). Two standards were used in measuring patient monitoring: the Health Plan Employer Data and Information Set (HEDIS) quality-of-care criterion calling for three contacts in 3 months and the FDA-recommended contact schedule totaling seven visits in 3 months. Time-series models compared postadvisory trends to the expected trend based on preadvisory measures. RESULTS: Less than 5% of all patients met FDA contact recommendations before the advisory, and the rate did not change after the advisory. A greater proportion of patients met the HEDIS contact criterion before the advisory (60% for children and 40% for adults), and the rate did not change after the advisory. A greater proportion of pediatric patients seen by a psychiatrist (80%) met the HEDIS criterion than those seen by a pediatrician (60%) or a non-pediatrician primary care physician (54%), and than adults seen by a psychiatrist (65%) or a primary care physician (37%). The proportions of pediatric patients who met the FDA recommendations did not differ by specialty. CONCLUSIONS: Contrary to expectations, the frequency of visits by patients with new episodes of depression treated with antidepressants did not increase after the October 2003 FDA advisory was issued.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279
Organizing Care for Patients with Chronic Illness
Wagner, E. H., Austin, B. T., & Korff, M. V. (1996) · The Milbank Quarterly · doi:10.2307/3350391 · Cited by 2,877
Valuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00006 · Cited by 182
Self-citation
Research works printed but not linked: 24
- US Food and Drug Administration, 2003, Oct 27
- US Food and Drug Administration, 2005, Class suicidality labeling language for antidepressants
- US Food and Drug Administration, 2005, Medication guide: about using antidepressants in children and teenagers
- US Food and Drug Administration, 2004, FDA Public Health Advisory: Worsening Depression and Suicidality in Patients Being Treated With Antidepressant Medications
- US Food and Drug Administration, Oct 15, 2 0 0 4 . h t t
- National Committee for Quality Assurance, 2004, HEDIS Volume 2: Technical Specifications
- National Committee for Quality Assurance, 2006, The State of Healthcare Quality
- 10.1007/s11020-005-3781-1 · DOI
- Scholle SH, 2005, J Manag Care Pharm, 11, S9
- 10.1097/01.mlr.0000128000.96869.1e · DOI
- 10.1136/bmj.310.6974.215 · DOI · Paper page
- 10.1089/cap.2006.16.25 · DOI · Paper page
- 10.1176/ajp.2007.164.6.884 · DOI · Paper page
- 10.1176/appi.ajp.2007.07010007 · DOI · Paper page
- 10.18553/jmcp.2006.12.1.43 · DOI · Paper page
- Cook TD, 1979, Campbell DT: Quasi-Experimentation: Design and Analysis Issues for Field Settings
- 10.2105/AJPH.90.12.1861 · DOI
- Stata, 2006, Intercooled Stata for Windows
- Stone M, 2006, Nov 16
- Stettin G, 2006, Am J Manag Care, 12, 453
- American Psychiatric Association, 2004, Oct 15
- 10.1046/j.1525-1497.2002.10321.x · DOI
- 10.1046/j.1525-1497.2002.11051.x · DOI · Paper page
- 10.1136/bmj.38683.710255.BE · DOI · Paper page
Cited by
A Model of Placebo Response in Antidepressant Clinical Trials
Rutherford, B. R., & Roose, S. P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040474 · Cited by 268
Hetrick, S. E., Robinson, J., Burge, E., Blandon, R., Mobilio, B., Rice, S. M., Simmons, M. B., Alvarez-Jimenez, M., Goodrich, S., & Davey, C. G. (2018) · JMIR Mental Health · doi:10.2196/mental.9041 · Cited by 151
“However, there are significant challenges to implementing routine and meaningful monitoring [21-23].”
BackgroundHoffman, K. B., Demakas, A. R., Dimbil, M., Tatonetti, N. P., & Erdman, C. B. (2014) · Drug Safety · doi:10.1007/s40264-014-0225-0 · Cited by 118
Rickard, N., Arjmand, H.-A., Bakker, D., & Seabrook, E. (2016) · JMIR Mental Health · doi:10.2196/mental.6202 · Cited by 118
“In practice, however, it remains difficult for clinicians or professional mental health service providers to obtain frequent monitoring in real time [13,14].”
Hetrick, S. E., Goodall, J., Yuen, H. P., Davey, C. G., Parker, A. G., Robinson, J., Rickwood, D. J., McRoberts, A., Sanci, L., Gunn, J., et al. (2017) · Crisis · doi:10.1027/0227-5910/a000422 · Cited by 31
“Our work (Hetrick, Thompson, et al., 2012; Page et al., 2009), consistent with work done in the United States (Morrato et al., 2008), showed that systematic and ongoing monitoring (which should include both assessment and recording) of depression and suicidal ideation severity was not adequately implemented.”
BackgroundResultInfluential
Metadata
- Authors
- Morrato, E. H., Libby, A. M., Orton, H. D., deGruy, F. V., Brent, D. A., Allen, R., & Valuck, R. J.
- Venue
- American Journal of Psychiatry
- Published
- 2008-01
- Volume
- 165
- Issue
- 1
- Pages
- 42-50
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2110440425
- Cited by
- 100
- References
- 3
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.